www.cancerindetail.com

Prostate Cancer Awareness Session for Gay & Bisexual Men

Jun 12, 2013 | citizenseye.org

The Leicester LGBT Centre is holding an awareness raising session for gay and bisexual men on the issue of prostate cancer. Gay and bisexual men entering, or beyond, their 40s must deal in one way or another with the prospect... Read more...

prostate cancer Leicester session bisexual awareness LGBT PROSTAID LE1 6HH NhS gay

image

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces …

Jun 12, 2013 | dreamdiet.net

hCG Diet Plans from Diet Doc Diet Doc has combined decades of scientific research with the knowledge and expertise of specially trained fast weight loss doctors, nurses and nutritionists and have developed America’s leading... Read more...

hCG Doc Diet prostate Plans cancer weight medically obesity nutritionist

image

Medicare to Pay for More FDG-PET Scans

Jun 12, 2013 | medpagetoday.com

WASHINGTON (MedPage Today) -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid... Read more...

FDG-PET scan Medicare CMS coverage cancer

image

Tara favorited Wolf's blog post Tommy Chong Beats Prostate Cancer with Hemp Oil and Proper Diet

Jun 11, 2013 | 12160.info

May 15, 2013 | By Dylan Charles Last June, the famous comedian, actor and pro-marijuana legalization advocate, Tommy Chong, reported to the world that he had been diagnosed with stage 1 prostate cancer and that he was seeking... Read more...

cancer Tommy Chong Oil Cannabis diet treatment blog legalization hemp cure healer supplement doctor

image

7th edition of the Walk of Courage 2013

Jun 12, 2013 | survivornet.ca

This year, the PROCURE Walk of Courage will take place on September 15th, 2013 at Parc Jean Drapeau. For the past 6 years the PROCURE Walk of Courage aims to spread awareness of prostate cancer and invites men to take control... Read more...

Courage Walk PROCURE 2013 Pagé prostate Jean Drapeau

Oz rainforest fruit may hold miracle cure for cancer sufferers

Jun 12, 2013 | onepakistan.com.pk

Melbourne : A life science company is perfecting a possible miracle cure for cancer from a fruit from the north Queensland rainforest. QBiotics based in Queensland believes that a compound extracted from the same fruit of the... Read more...

rainforest cancer cure miracle fruit prostate cancerWashington anti-cancer riskNew blushwood QBiotics soft drink wound healing tumor revealed.The

image

Cancer survivor serves caution about bone health

Jun 13, 2013 | survivornet.ca

Thursday, June 13 2013 BRAMPTON — Brampton resident Kim Winchcombe, 54, a breast cancer survivor, wants individuals with certain type of cancer to have a frank conversation with their physicians about protecting their bones.... Read more...

cancer bone Winchcombe survivor breast prostate CCSN health complication

Provenge Success Stories

Jun 11, 2013 | prostate.net

Provenge Success Stories Provenge success stories provide hope for prostate cancer patients. Richard Hamablet is a 15-year prostate cancer survivor who has been through multiple prostate cancer treatments, but the cancer always... Read more...

Provenge prostate cancer vaccine Hamablet Malhora Frohlich

Prostate cancer on ‘Medtalk’

Jun 12, 2013 | tempo.com.ph

Posted by Online on Jun 13th, 2013 // No Comment PROSTATE cancer is the sixth leading cause of cancer-related death in the world. This type of cancer develops in men over age 50. Early detection will stop it from spreading.... Read more...

Medtalk prostate cancer Solar

Propecia and Proscar (Infographic)

Jun 11, 2013 | prafulla.net

Propecia side effects include increased risk of prostate cancer, erectile dysfunction, diminished sex drive, among others. Propecia is a male pattern baldness drug with serious side effects such as an increased risk of getting... Read more...

Propecia drug effect Merck side prostate pharmaceutical

Getting dad to the doctor

Jun 11, 2013 | bclocalnews.com

Dr. John Kinahan, a urologist, urges men over 40 to get a prostate check up this Father’s Day. No one is ever excited for a prostate exam. “It’s just a finger exam, a digital rectal exam. That part takes four seconds. If you... Read more...

John Kinahan Kinahan prostate doctor cancer exam urologist getting rectal check-up

image

Insulin-like growth factor IEc linked to prostate cancer

Jun 13, 2013 | foodconsumer.org

Wednesday June 12, 2013 (foodconsumer.org) -- Anything that promotes growth potentially promotes the growth of cancer. A new study in Anticancer Research suggests that insulin-like growth factor IEc also known as Mechano growth... Read more...

IEc prostate IGF-IEc cancer growth expression Mechano factor cytoplasmic

Prostate Enzyme Enables Detection Of Metastases During Molecular Imaging

Jun 13, 2013 | nucleonica.net

prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer... Read more...

prostate enzyme imaging detection Vallabhajosula cancer radiochemistry PSMA

image

PET/MR effective for imaging recurrent prostate cancer

Jun 11, 2013 | bio-medicine.org

Vancouver, British Columbia When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or... Read more...
All similar articles: 64 »

MR prostate PET recurrent cancer choline imaging metastatic C-11 image CT

image

June is Men’s Health Awareness Month

Jun 10, 2013 | northjersey.com

Prostate cancer screening tests save lives. Will your health insurance pay for such a test? The National Prostate Cancer Coalition issued its first state by state report card on how well the states are doing in mandating health... Read more...

screening test Awareness prostate Month Medicare insurance Health exam PSA cancer cover rectal self-funded www.pcc-nj.org coverage mammogram Card&Betsy 973-492-2828

Analysis of circulating regulatory T cells (CD4+CD25+CD127−) after cryosurgery in prostate cancer

Jun 10, 2013 | nature.com

1Department of Interventional Therapy, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin 300060, China 2Department of Radiology, Tianjin Medical University General Hospital, Tianjin 300052, China Correspondence: Dr Z... Read more...

Tregs cryosurgery PCa CD4 CD127− CD25 cell patient Treg tumor T

image

A 32-gene risk index: a new prognostic approach for prostate cancer progression

Jun 10, 2013 | nature.com

1Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA 2Graduate School of Southern Medical University, Guangzhou, Guangdong 510515, China 3Department of Urology, Guangzhou... Read more...

32-gene BCR RP prognostic patient index risk prostate adjuvant progression cancer

image

Ra-223: New Arrow in Prostate Cancer QuiverRa-223: New Arrow in Prostate Cancer Quiver

Jun 10, 2013 | medscape.com

Drs. Johann de Bono and Howard Scher discuss the fifth active agent in prostate cancer as well as imaging as a biomarker and upcoming immunoconjugates, as reported at ASCO 2013. Medscape Oncology (Source: Medscape Today Headlines) Read more...
All similar articles: 146 »

Medscape clinical drug&disease medical CME Smartphone Reference CE Complete

A fusion at the root of prostate cancer

Jun 10, 2013 | nature.com

YCR Cancer Research Unit, Dept of Biology, University of York, York YO10 5DD, UK Correspondence: Dr NJ Maitland, Many hematopoietic malignancies have oncogenic gene fusions, like BCR-ABL, in their tumor-initiating cells. This... Read more...

cell TMPRSS2-ERG fusion prostate cancer stem clonal tumor TMPRSS2 androgen mutation

Cancer survivors ‘Celebrate Life’ at CTCA

Jun 10, 2013 | suntimes.com

Donald McEntee, a prostate cancer survivor from Gurnee, joined more than 100 five-year cancer survivors for an emotional and momentous tree-planting ceremony at Cancer Treatment Centers of America (CTCA) at Midwestern Regional... Read more...

CTCA survivor McEntee cancer Life Midwestern Celebrate survivorship five-year prostate

Cefter Dry Syp 50ml

Jun 9, 2013 | matrixdirectindia.com

Generally these matters are too ecocnomic as the customer cannot acquisition outside he was harmed, or received a bad amount, until continued after the sale, provided ever. Yep. This, essentially, is the advice assymetry... Read more...

Cefter Syp affliction AmTrust 50ml OTS CFPA Р amble treatment Buffett patient

Flaxseeds: From Linen to Healing

Jun 11, 2013 | health-and-beauty-nut.com

T en thousand years ago, flax was one of the first plants farmed for purpose other than food. Flax has a fibrous stem, and the fibers were woven into cloth, eventually linen. But flax seeds also produce an oil (flaxseed or... Read more...

flaxseed estrogen flax linen breast cancer researcher Lignans prostate lignin ALA cholesterol flash hot fiber

image

Health Facts For Men

Jun 9, 2013 | freelanceglobalmedia.com

Health facts every man needs to know Many facts related to healthy living are true regardless of your gender; however, men also have their own unique health concerns they need to pay attention to. To help keep your health in... Read more...

fizzy health drink tooth study fact brush caffeine periodontitis gum prostate cancer weight age erectile diet coffee risk cent happiness-boosting happy dysfunction

image

New Products for pharmacists

Jun 9, 2013 | modernmedicine.com

NEW RX In May, FDA approved Bayer’s Xofigo (radium Ra 223 dichloride), a treatment for advanced prostate cancer, three months ahead of schedule under its priority review program. Xofigo is indicated for men who have already... Read more...

Osphena ProEPA Ilaris SJIA IL-1 Promius treatment Xofigo EPA VVA DerMend patient FDA symptom beta effect iPLEDGE

Picking the Optimal Duration of Hormonal Therapy in Men With High-Risk and Locally Advanced...

Jun 11, 2013 | semradonc.com

The optimal duration of hormonal therapy when combined with radiation for men with high-risk and locally advanced prostate cancer remains under active study. Based on the results of randomized controlled trials, durations of... Read more...

James W. Denham duration hormonal therapy locally optimal prostate advance androgen Gleason suppression high-risk extracapsular nonhormonal cancer 28-36

Hypofractionation for Clinically Localized Prostate Cancer

Jun 11, 2013 | semradonc.com

This manuscript reviews the clinical evidence for hypofractionation in prostate cancer, focusing on data from prospective trials. For the purposes of this manuscript, we categorize hypofractionation as moderate (2.4-4 Gy per... Read more...

Alvin R. Cabrera hypofractionation prostate cancer trial randomized Gy extreme 2.4-4

Comparing Dosimetric, Morbidity, Quality of Life, and Cancer Control Outcomes After 3D Conformal,...

Jun 11, 2013 | semradonc.com

New radiation technologies have been developed and adopted for clinical use in prostate cancer treatment in response to a need to deliver dose-escalated radiation therapy while minimizing treatment-related morbidity. The goal... Read more...

Kevin A. Pearlstein dosimetric morbidity radiation outcome cancer intensity-modulated therapy dose-escalated prostate

Trouble-Free Advice Of Prosvent Review – An Intro

Jun 10, 2013 | mnforestcertification.org

Author: Elmer R. C. Torres-Browne – The number of adult men impacted by www.prosventreviewer.com is practically identical to the number of girls influenced by breast cancer but mortality of prostate cancer is less than breast... Read more...

Mnforestcertification prostate cancer www.prosventreviewer.com ejiculate urethra vesica ejiculation prosventreviewer.com Torres-Browne diet gland PSA

image

Doctor drawing experimental cancer drugs to Las Vegas

Jun 10, 2013 | lvrj.com

JESSICA EBELHAR/LAS VEGAS REVIEW-JOURNAL Craig Becker of Denver, left, talks with Dr. Nicholas Vogelzang at Comprehensive Cancer Centers of Nevada . Becker, who has prostate cancer, is being treated with a drug recently... Read more...
All similar articles: 433 »

Vogelzang cancer Leany drug radium-223 prostate Las Vegas patient Becker Comprehensive Nevada

image

Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013

Jun 10, 2013 | sectorpublishingintelligence.co.uk

Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013TARRYTOWN, N.Y., June 10, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has reported findings from studies of... Read more...

Progenics SNMMI prostate PSMA cancer Pharmaceuticals MIP-1095 oncology

image